Table of Contents
I. $1000 Prize to anyone who can break this Code http://hegp.genenetwork.org/challenge
II. Adolescent Brain Cognitive Development SM (ABCD) Study COVID-19 supplemental data release is now available on the NIMH Data Archive(NDA) NDA website
III. Call for Abstracts for NIDA Genetics and Epigenetics Consortium Meeting Due Feb 1, 2021
I. $1000 Prize to anyone who can break this Code http://hegp.genenetwork.org/challenge
Richard Mott and Pjotr Prins developed a homomorphic encryption method for genotypes and phenotypes (HEGP) as described in this open access paper supported by NIDA P30DA044223, NIGMS R01 GM-123489, and Biotechnology and Biological Sciences Research Council grants BB/S017372/1, BB/R01356X/1, HBB/P024726/1, and BB/M011585/1. HEGP mixes up genotypes and phenotypes to make them indistinguishable from random numbers, but such that the randomization has no effect on the outcome of testing genetic association or of estimating key parameters such as heritability or the effects of individual genetic variants. It makes it possible to share encrypted datasets and perform large-scale federated mega-analyses as if the unencrypted data had been shared. Richard Mott and Pjotr Prins are offering a $1000 Prize to anyone who can break the code http://hegp.genenetwork.org/challenge. Please forward to anyone with code breaking expertise.
II. Adolescent Brain Cognitive Development SM (ABCD) Study COVID-19 supplemental data release is now available on the NIMH Data Archive(NDA) NDA website
The ABCD COVID-19 data release consists of survey responses from ABCD families about the impact of the pandemic on their lives. Surveys were sent electronically to all ABCD participants and their parent/guardian in May, June, August and December of 2020. Youth and parents/guardians were asked separately about school attendance and activities, sleep, daily routines, physical activity, mental health, screen time, racism/discrimination in relation to COIVD-19, COVID attitudes and practices, and coping behaviors. Importantly, researchers will be able to link data from these surveys to data from the main ABCD study visits, including those that occurred prior to the pandemic. Future releases will include data from subsequent surveys. Visit the NDA website for more information.
III. Call for Abstracts for NIDA Genetics and Epigenetics Consortium Meeting Due Feb 1, 2021
The Genetics and Epigenetics Cross Cutting Research Team of the National Institute on Drug Abuse invites you to submit an abstract for the March 8-10, 2021 Virtual NIDA Genetics and Epigenetics Consortium Meeting. Oral presentations will be conducted through Webex. Submissions selected for poster presentations will have the opportunity to present their work through a SLACK Channel. Presenters using a SLACK channel must post hyperlinks to their presentations. Presentations uploaded as a file to SLACK will be removed. We encourage hyperlinks to short (e.g. 5 to 10 slides) slide decks (e.g. via Box, Google Drive or other data-sharing service) and presentations via Zoom or other similar platform. Detailed instructions will be shared in mid-February and practice sessions will be held prior to the meeting.
Please submit your abstract in the following format to NIDAGenetics@leedmci.com. By February 1, 2021:
Submitter Name:
Submitted email:
PI Name (if different):
PI email (if different):
Clever title for your abstract
First Name Last Name1, First Name Last Name1,2, First Name Last Name3, and First Name Last Name1,4
1Department, University; 2Department, University; 3Department, University; 4Department, University
The Abstract should discuss the background, rationale/significance, hypothesis, results and discussion. The font size should be Arial 11 pt. The body of the abstract should be 250 words, maximum and fully justified. Please submit the abstract as a word document. Abstracts are due by Midnight PST on February 1, 2021. Abstracts not conforming to this format or sent to another email will not be accepted for review and may be returned to the sender. Abstracts sent to another email will not be returned.
See examples at: (2020 NIDA Genetics Consortium Meeting Abstracts).
The goals of the meeting are to:
The NIDA Genetics and Epigenetics Cross-Cutting Research Team will select up to 30 abstracts for short talks. We may invite some investigators to serve as panel discussants. Abstracts not selected for talks may be assigned poster presentations. Abstracts should focus on the genetics and epigenetics of substance abuse in humans or in model systems. We encourage submissions across all career stages (e.g. graduate students, postdoctoral scientists, junior and senior faculty). Abstracts are due by Midnight PST on Monday, February 1, 2021. Decisions on acceptance of poster presentations and short talks will be made on a rolling basis.
----------------------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
Robert F. Leeman, Ph.D.
Associate Professor
Mary F. Lane Endowed Professor
Department of Health Education and Behavior
College of Health and Human Performance
Co-Director, NIH/NIAAA T32: Translational Science Training to Reduce the Impact of Alcohol on HIV Infection
Associate Director, Southern HIV & Alcohol Research Consortium (SHARC)
University of Florida
Florida Gymnasium, Room 14
PO Box 118210 Gainesville, FL 32611
Phone: (352) 294-1808
Email: robert.leeman@ufl.edu
Faculty webpage: Robert Leeman, Ph.D. - College of Health and Human Performance (ufl.edu)
Lab webpage: EDGE Lab - College of Health and Human Performance (ufl.edu)
Twitter: @LeemanRobertF
POSTDOCTORAL FELLOWSHIP
IN HIV AND ALCOHOL RESEARCH
Southern HIV and Alcohol Research Consortium (SHARC)
University of Florida
The Southern HIV and Alcohol Research Consortium (SHARC) at the University of Florida seeks Postdoctoral Fellows interested in translational science research and training focused on reducing the impact of alcohol on HIV infection, behavioral and clinical interventions, and/or neurocognition and brain science.
Fellows are supported by a T32 training grant funded by the NIH National Institute on Alcohol Abuse and Alcoholism.
Postdoctoral Fellows will develop an original research program under the guidance of a faculty mentor, participate in research seminars and training experiences, and engage in individual and group mentoring sessions with distinguished faculty mentors including Co-Directors Drs. Robert Cook, Robert Leeman, and Robert Lucero together with faculty colleagues representing diverse disciplines across the university.
SHARC faculty mentors are affiliated with six departments and four colleges at the University of Florida, including:
Clinical & Health Psychology: Jeff Biossoneault, PhD; Ronald Cohen, PhD;
Eric Porges, PhD; Catherine Price, PhD, ABPP; Adam Woods, PhD
Epidemiology: Robert L. Cook, MD, MPH; Xinguang Chen, MD, PhD, FACE;
Linda Cottler, PhD, MPH, FACE; Mattia Prosperi, MEng, PhD; Yan Wang, PhD
Health Education & Behavior: Robert Leeman, PhD; JeeWon Cheong, PhD; Jalie Tucker, PhD, MPH
Nursing: Robert Lucero, PhD, MPH, RN, FAAN; Anna McDaniel, PhD, RN, FAAN; Diana Wilkie, PhD, RN, FAAN
Pathology: Marco Salemi, PhD
Psychiatry & Psychology: Sara Jo Nixon, PhD
For more information about the SHARC T32 training program and to learn about application requirements, we invite you to visit our program website at
https://sharc-research.org/get-involved/t32-training/ or email sharct32@phhp.ufl.edu or any of the faculty mentors listed above.
Preliminary inquiries should include the following documents and may be submitted by email to sharct32@phhp.ufl.edu:
· Statement of Interest
· Curriculum Vitae
Applying:
All appointments to this training grant are restricted to U.S. citizens, legal permanent residents of the U.S. and noncitizen nationals. Persons on temporary or student visas or who require visa sponsorship are not eligible for this training grant.
Start Date:
Review of applications will be conducted on a rolling basis. Initial appointment will be for 12 months and is renewable annually up to two years contingent upon satisfactory performance and availability of funding.
Compensation:
Trainees receive stipends at standard NIH levels (NIH levels are described here: (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-070.html) as well as financial support for research and travel expenses and health insurance.
Diversity and Inclusion:
The University of Florida is an equal opportunity institution. Individuals from underrepresented populations are strongly encouraged to apply for this postdoctoral opportunity. We highly encourage the applications of scholars from diverse backgrounds and experiences, scholars of color, scholars from rural backgrounds, scholars who have been the first in their families to pursue postsecondary or postgraduate education, and scholars interested in using academic research to drive social change.
Dear Colleagues,
I am writing to let you know we will be accepting applications for post-doctoral fellows on our NIDA-supported training grant in the Department of Behavioral Science at the University of Kentucky (T32 DA035200; "Research Training in Drug Abuse Behavior"). Applications are due at noon Eastern on April 15, 2021; only US citizens or permanent residents are eligible. Please contact me at crush2@email.uky.edu for more details or a list of training faculty.
Thank you,
Craig Rush, Director, T32DA035200
Dear Colleagues,
The U.S. Preventive Services Task Force (USPSTF) just released final recommendations and an evidence summary on interventions for tobacco cessation in adults, including pregnant persons. A clinician summary is also available on the Task Force website, which provides guidance to primary care clinicians for using the recommendation in practice.
To view the recommendation and evidence summary, please click here: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
Please forward to interested colleagues.
Thank you.
Jacob S. Marzalik, MA
Project Manager, Clinical Practice Guidelines
Practice Transformation and Quality, Practice Directorate
American Psychological Association
750 First Street NE, Washington, DC 20002-4242
202-336-5872
All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.
From: Agency for Healthcare Research and Quality (AHRQ) <updates@subscriptions.ahrq.gov>
Sent: Tuesday, January 19, 2021 11:50 AM
To: Marzalik, Jacob <JMarzalik@apa.org>
Subject: Final Recommendation Statement: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons
|
| This email was sent to jmarzalik@apa.org using GovDelivery Communications Cloud on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 5600 Fishers Lane, Rockville, MD 20857 · 301-427-1364 |
CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe.
Dear Colleagues,
I am hiring a Research Coordinator II in my research group in the Department of Health Education & Behavior at the University of Florida to contribute to our studies on etiology of addictive behaviors and development/testing of new interventions to ameliorate these behaviors, particularly technology-based interventions, primarily (though not exclusively) in the young adult population. This RC II will be in an overseeing and supervisory role so I am looking for someone with prior experience. This person will also contribute to academic tasks like literature searches, potentially preliminary data analysis and collaboration on conference presentations and manuscripts in which we use great words like ameliorate. The link is below. Please spread widely and don’t hesitate to reach out with any questions. As of now, we are a group with three professional/paid research assistants, three doctoral students, an MPH intern and about a dozen undergraduates. I am biased but I feel that we have a good culture where we get along well and work collaboratively.
Best,
Rob Leeman
https://explore.jobs.ufl.edu/en-us/job/515453/research-coordinator-ii
Robert F. Leeman, Ph.D.
Associate Professor
Mary F. Lane Endowed Professor
Department of Health Education and Behavior
College of Health and Human Performance
Co-Director, NIH/NIAAA T32: Translational Science Training to Reduce the Impact of Alcohol on HIV Infection
Associate Director, Southern HIV & Alcohol Research Consortium (SHARC)
University of Florida
Florida Gymnasium, Room 14
PO Box 118210 Gainesville, FL 32611
Phone: (352) 294-1808
Email: robert.leeman@ufl.edu
Faculty webpage: http://hhp.ufl.edu/about/faculty-staff/leeman_robert/
Lab webpage: http://hhp.ufl.edu/faculty-research/labs/edge-lab/
Twitter: @LeemanRobertF
_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28
